# 3 Limus Agent Eluting Stents With Different Polymer Coating

> **NCT00598676** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 2600 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** biodegradable polymer Rapamycin-eluting stent
- **DEVICE:** permanent polymer rapamycin-eluting stent (Cypher)
- **DEVICE:** permanent polymer everolimus-eluting stent (Xience, Promus)

## Key facts

- **NCT ID:** NCT00598676
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 2600 (ACTUAL)
- **Last updated:** 2010-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598676, "3 Limus Agent Eluting Stents With Different Polymer Coating". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00598676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*